Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
5.40
-0.18 (-3.23%)
Mar 31, 2025, 12:13 PM EDT - Market open
Xeris Biopharma Holdings Employees
Xeris Biopharma Holdings had 394 employees as of December 31, 2024. The number of employees increased by 17 or 4.51% compared to the previous year.
Employees
394
Change (1Y)
17
Growth (1Y)
4.51%
Revenue / Employee
$515,406
Profits / Employee
-$139,178
Market Cap
831.28M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
XERS News
- 3 days ago - Xeris Announces Changes to Its Board of Directors - Business Wire
- 14 days ago - Xeris Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx™ (glucagon) for Use as a Diagnostic Aid - Business Wire
- 25 days ago - Xeris Biopharma Holdings, Inc. (XERS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 25 days ago - Xeris Biopharma Delivers Record Fourth Quarter and Full-Year 2024 Results; and Announces 2025 Guidance - Business Wire
- 4 weeks ago - Xeris Biopharma to Report Fourth Quarter and Full-Year 2024 Financial Results on March 6, 2025 - Business Wire
- 5 weeks ago - Xeris Appoints Anh Nguyen, MD, MBA as Chief Medical Officer - Business Wire
- 7 weeks ago - Xeris to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - The American Diabetes Association and Xeris Pharmaceuticals Announce National Collaboration to Provide Life-Saving Hypoglycemia Education and Awareness - PRNewsWire